Pfizer receives USFDA approval for Elrexfio for the treatment of relapsed or refractory multiple myeloma
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
The medical device sector is considered as one of the sunrise sectors in the country
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
Subscribe To Our Newsletter & Stay Updated